How should thyroid function be assessed and managed in a woman with polycystic ovary syndrome (PCOS)?

Thyroid Assessment and Management in PCOS

All women with PCOS must be screened for thyroid disease with a TSH level as part of their initial diagnostic workup, as thyroid disorders are a key exclusion criterion for PCOS diagnosis and subclinical hypothyroidism occurs in approximately 20% of PCOS patients. 1, 2, 3

Initial Thyroid Screening

When evaluating a woman with suspected or confirmed PCOS, measure:

• Thyroid-stimulating hormone (TSH) - mandatory screening test 1
• Free T4 - if TSH is abnormal
• Anti-TPO antibodies - consider in patients with elevated TSH or strong clinical suspicion

The ACOG guidelines explicitly list thyroid disease among conditions that must be excluded before diagnosing PCOS 1, 2. This is critical because thyroid dysfunction can mimic PCOS symptoms and must be ruled out first.

Why This Matters: The PCOS-Thyroid Connection

Subclinical hypothyroidism (SCH) is significantly more prevalent in PCOS patients (approximately 15-20%) compared to the general population (1.5-6%). 3, 4, 5 Recent meta-analysis data from 2025 demonstrates that SCH in PCOS patients is associated with:

• Worsened insulin resistance - HOMA-IR increases by 0.78 units and fasting insulin by 2.38 μIU/mL 3, 6
• Aggravated dyslipidemia - higher total cholesterol, LDL, and triglycerides 4, 7
• Impaired glucose tolerance 4
• Reduced fertility outcomes - lower ovulation induction success rates 8, 9

Management Algorithm

For Normal Thyroid Function (TSH within reference range):

• Recheck TSH annually, as PCOS patients have higher risk of developing thyroid dysfunction over time
• More frequent monitoring (every 6 months) if patient has positive TPO antibodies or family history of thyroid disease

For Subclinical Hypothyroidism (Elevated TSH, Normal Free T4):

Treat with levothyroxine if:

• TSH > 10 mIU/L (treat regardless of symptoms)
• TSH > upper limit of normal AND patient is attempting pregnancy 2
• TSH > upper limit of normal AND patient has metabolic complications (insulin resistance, dyslipidemia)
• Patient is symptomatic

Target TSH: Aim for TSH < 2.5 mIU/L, particularly in women attempting conception 10

The 2025 evidence shows that even mild TSH elevations worsen the already-present insulin resistance and metabolic dysfunction in PCOS 3, 4, 6. While one 2021 study suggested treatment may not significantly alter lipid profiles 7, the weight of recent evidence (2025-2026) demonstrates measurable metabolic benefits from thyroid hormone replacement 4, 6.

For Overt Hypothyroidism (Elevated TSH, Low Free T4):

• Initiate levothyroxine immediately
• Target TSH < 2.5 mIU/L
• Recheck TSH every 6-8 weeks until stable, then every 6 months

For Hyperthyroidism:

• Refer to endocrinology for management
• Note: Hyperthyroidism was found in 31% of PCOS patients in one tertiary center study 5, though this is higher than typically reported

Special Considerations

Pregnancy Planning:

• Women with PCOS attempting conception should have TSH optimized to < 2.5 mIU/L before conception 10
• If already on levothyroxine, increase dose by 30% (two extra tablets per week) immediately upon missed period, then check TSH 10
• TSH levels directly correlate with ovulation induction success rates 9

Metabolic Monitoring:

• The combination of PCOS and SCH creates additive metabolic risk
• Screen for type 2 diabetes with oral glucose tolerance test (fasting and 2-hour glucose after 75g load) 1, 2
• Check fasting lipid panel including total cholesterol, LDL, HDL, and triglycerides 1

Common Pitfalls to Avoid

1. Don't skip thyroid screening - It's not optional in PCOS evaluation; thyroid disease must be excluded to make the diagnosis 1, 2

2. Don't use "normal" population TSH cutoffs - Consider treatment at lower TSH thresholds in PCOS patients, especially those with metabolic complications or attempting pregnancy

3. Don't ignore subclinical hypothyroidism - Even mild TSH elevations (2.5-10 mIU/L) worsen insulin resistance and metabolic outcomes in PCOS 3, 4, 6

4. Don't forget to recheck - Annual TSH monitoring is essential as thyroid dysfunction can develop over time in PCOS patients

5. Don't overlook Hashimoto's thyroiditis - Anti-TPO antibodies are more prevalent in PCOS (12.4% vs 2.7% in controls) 4, 11, and these patients need closer monitoring

The evidence strongly supports that addressing thyroid dysfunction in PCOS patients improves both metabolic and reproductive outcomes, making thyroid assessment a critical component of comprehensive PCOS management.